Status:
COMPLETED
ECG-guided Immediate Primary PCI for Culprit Vessel to Reduce Door to Device Time
Lead Sponsor:
Beijing Luhe Hospital
Conditions:
Myocardial Infarction
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
No consensus exists about which coronary artery should be firstly catheterized in primary percutaneous coronary intervention (PCI). The aim of the present study was to compare door-to-balloon time (D2...
Eligibility Criteria
Inclusion
- Patient must be \> 18 years of age
- Patients have typical chest pain for at least 20 minutes and have ECG changes typical for STEMI (ST elevation≥2mm in two continuous precordial leads or ST elevations≥1mm in two limb leads or new left bundle branch block) or ECG changes compatible with true posterior MI
- Symptoms ≥ 30 min and ≤12 hours
- Patient and treating interventional cardiologist agree for randomization
- Patient provides written informed consent
- Diagnostic and therapeutic intervention performed through transradial artery approach
- Palpable radial artery.
Exclusion
- Concurrent participation in other investigational study
- Current platelet count \<100 x 10\^9cells/L or Hgb \<10 g/dL
- Absence of radial artery pulsation
- Active bleeding or significant increased risk of bleeding, severe hepatic insufficiency, current peptic ulceration, proliferative diabetic retinopathy
- Uncontrolled hypertension
- Prior CABG surgery
- Fibrinolytic therapy for current MI treatment
- patient have a life expectancy of \<180days
Key Trial Info
Start Date :
February 10 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 31 2019
Estimated Enrollment :
560 Patients enrolled
Trial Details
Trial ID
NCT03272451
Start Date
February 10 2017
End Date
July 31 2019
Last Update
June 1 2022
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Beijing Luhe hospital
Beijing, China, 101149
2
Beijing Luhe hospital
Beijing, China